TARDBP and myeloid sarcoma: Recently, these findings were expanded to include 12 additional MS cases and six control cases, and demonstrated increased nucleocytoplasmic mislocalization of hnRNP A1 and TDP-43 in neurons from MS patients compared to controls [129].